Skip to main content
Account

Table 1 Exposure (mean value) of paclitaxel in plasma, tumor, liver, and spleen following intravenous administration

From: Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity

Tissue AUC0-8 (μM × h)

Formulation

 

Cremophor EL:ethanol

Nanosuspension

Plasma

74.7

2.1

Tumor

52.1

17.5

Liver

269.1

1,701.1

Spleen

85.2

147.5

Navigation